1987 Cadillac Eldorado Gasoline on 2040-cars

Auto blog

Genesis cars win accolades, offer value — so why are sales so bad?

My high-school buddy Brent Cormier was so smitten with the Genesis G80 when he saw it at an event I hosted at SXSW in 2016 he bought a used 2013 Hyundai Genesis a short time later and fell in love with the car. "It surpasses my every expectation," said Cormier, a self-described "renaissance man" who owns and runs a real estate agency with his wife Laura, is a food service executive chef and part owner of Austin-based Thin the Herd Guitars. "I was locked into Mercedes and Audi for 10 years," he added. "And felt trapped in an endless pit of maintenance costs." After owning the Genesis over the past two years — including using it as an Uber and Lyft driver to earn extra cash — Cormier learned what some frugal luxury sedan buyers and a handful of car reviewers have discovered: Genesis offers great bang for the buck compared to other premium brands and can compete with the best in terms of performance, features and comfort. Hyundai's luxury brand also earned a prominent third-party endorsement last week when for the first time Genesis topped J.D. Power's 2018 APEAL study, surpassing German luxury-performance icon Porsche. The APEAL study (which stands for Automotive Performance, Execution and Layout) "measures owners' emotional attachment and level of excitement across 77 attributes," ranging from performance to comfort, and asks nearly 68,000 owners of new 2018 models to score vehicles on a 1,000-point scale. In its second year ranked as a stand-alone brand, Genesis earned an APEAL score that bumped it up 15 points to 884 and helped push it past Porsche — and past BMW, Lincoln, Mercedes-Benz, Audi, Volvo, Cadillac, Land Rover and Lexus, in order of ranking. Last month, Genesis also topped J.D. Power's Initial Quality Survey (IQS) for the first time this year. And both its models were awarded Top Safety Pick Plus ratings by the Insurance Institute for Highway Safety, among 11 Plus ratings in all for Korean vehicles. Despite high J.D. Power rankings and great reviews, Genesis U.S. sales were off 50 percent for the first six months of 2018 compared to 2017, and in June Genesis sold only 796 vehicles — the first time U.S. numbers dropped below 1,000 in a month. Part of Genesis's APEAL and IQS success can be attributed to its small product lineup: just two models, the G80 and G90 sedans, with a third, the 2019 G70, launching later this year. And while those numbers may help in J.D.

2016 Cadillac CT6 First Drive [w/video]

Cadillac moved to New York, renamed its cars and crossovers, and made cutting-edge technology one of its pillars. It's fighting hard to attract new customers and kill its outdated reputation as an old-man car brand in the United States. Change happens slowly, and then sometimes, all at once. Enter the 2016 Cadillac CT6. This is Cadillac's range-topping sedan. It's almost as long as the Mercedes S-Class and BMW 7 Series, yet in some configurations, it's lighter than their smaller siblings, the E-Class and 5 Series. The CT6 is a rolling showcase of General Motors' latest and best technologies, with potential breakthrough features like Super Cruise semi-autonomous driving waiting in the wings. It comes in a wide variety of flavors. The CT6 starts as low as $54,490 with a four-cylinder engine and rear-wheel drive, which is the car that Cadillac hopes will be cross-shopped with the mid-tier Germans. The top-end CT6 Platinum with all-wheel drive and the 404-horsepower V6 begins at $84,460, and it could make S-Class and 7 Series buyers rethink American luxury. Put simply, the CT6 means everything to Cadillac, but it will mean different things to its customers. It can be the executive chauffeur with all the backseat accouterments. Or it can be the massive yet somehow kinda sporty and nimble rear-wheel-drive sedan that weighs only 3,657 pounds. We tried both versions and came away impressed with both the strategy and the execution. It's a little strange to think that Cadillac doesn't offer a V8 in its biggest sedan. Taking the wheel on a sunny, cool day in rural San Diego County, we wonder if a 2.0-liter four-cylinder engine has what it takes to really move this giant. Our concerns quickly dissipate – this engine is also under the hood of the Chevy Camaro, and its 265 hp and 295 pound-feet of torque are more than up for the task. The big sedan handles curvy mountain roads adeptly. There's not a lot of roll for a car this size, even when we're aggressively whipping through tight turns. This poise comes from the CT6's rigid, lightweight aluminum and steel structure called Omega. We switch through the driving modes but settle on sport for the dash to the lunch spot. The steering is surprisingly tight and the brakes have strong response with little pedal travel. After a quick bite in an old mining town called Julian, we take off in the spotlight CT6, the Platinum trim, powered by the 3.0-liter twin-turbo V6. It's an enjoyable car to stretch out on the highway.

GM delivers best Q3 sales since 1980, 2.4M vehicles sold

People are a weird sort. Even after registering over 70 recalls through the first three-quarters of 2014, General Motors saw its best Q3 results since Jimmy Carter was in the White House, registering over 2.4 million global sales between June and September on the back of strong results in the US and China.
US sales were marshaled by good results for GM's pickups, the Chevrolet Silverado and GMC Sierra, which bumped the manufacturer's truck market share to 35.6 percent, up nearly three points from Q1 2014. Buick has seen healthy growth as well, with the Encore dominating its segment for the sixth month running.
It was China, though, that really bolstered GM's sales, as the company's efforts to top last year's record-setting 3.16 million units continued apace. Small SUV sales saw massive growth, with Encore, Chevrolet Trax and Captiva figures jumping 90 percent in Q3. Brand-wise, Chevrolet, Cadillac and Buick all saw sales gains in the PRC, with each recording double-digit year-over-year jumps. Cadillac sales alone were up 63 percent compared to the first nine months of 2013.